What is VivaQuant?
VivaQuant operates within the digital health sector, specializing in remote cardiac monitoring services for clinics and hospitals under its Rhythm Express brand. The company's core offering is a highly differentiated mobile cardiac telemetry (MCT) wearable, designed for comfort and extended wear of up to 30 days. This device facilitates near real-time observation of patient heart rhythms, providing accurate diagnostic data through proprietary noise-canceling algorithms for high-clarity ECGs and machine learning-enabled wavelet analytics for precise arrhythmia identification. VivaQuant ensures 24/7/365 oversight of patient data, translating millions of heartbeats into actionable information to aid physicians in diagnosis and the establishment of life-saving care plans.
How much funding has VivaQuant raised?
VivaQuant has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
What's next for VivaQuant?
With substantial expansion capital secured, VivaQuant is poised for accelerated growth and further development of its remote cardiac monitoring platform. The company's Series B/C stage financing indicates a focus on scaling operations, enhancing its technological capabilities, and potentially expanding its market reach. Future strategic initiatives are likely to center on leveraging its advanced analytics and wearable technology to capture a larger share of the growing digital health and remote patient monitoring market, aiming to solidify its position as a leader in cardiac diagnostics.
See full VivaQuant company page
